| # | Drug | Count |
|---|---|---|
| 0 | TIRZEPATIDE | 1183 |
| 1 | ADALIMUMAB | 817 |
| 2 | ERGOCALCIFEROL | 796 |
| 3 | OMEPRAZOLE MAGNESIUM | 777 |
| 4 | ASPIRIN | 776 |
| 5 | ASPIRIN 81 MG | 757 |
| 6 | ASPIRIN 325 MG | 756 |
| 7 | ACETAMINOPHEN | 729 |
| 8 | PREDNISONE | 715 |
| 9 | METHOTREXATE SODIUM | 655 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 133 | 0.0386 |
| 1 | TRIMIPRAMINE | 34 | 0.0310 |
| 2 | ERGOCALCIFEROL | 796 | 0.0268 |
| 3 | GOLD | 137 | 0.0236 |
| 4 | TERBUTALINE SULFATE | 38 | 0.0207 |
| 5 | PSYLLIUM HUSK | 20 | 0.0148 |
| 6 | ZOLBETUXIMAB | 22 | 0.0144 |
| 7 | CHROMIC CHLORIDE | 12 | 0.0139 |
| 8 | DICLOFENAC POTASSIUM TABLETS | 91 | 0.0105 |
| 9 | HYALURONATE SODIUM | 16 | 0.0104 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 2199 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1665 |
| 2 | Corticosteroid [EPC] | 1502 |
| 3 | Benzodiazepine [EPC] | 1195 |
| 4 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 1183 |
| 5 | Kinase Inhibitor [EPC] | 974 |
| 6 | Proton Pump Inhibitor [EPC] | 965 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 806 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 676 |
| 9 | Vitamin C [EPC] | 676 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | l-Thyroxine [EPC] | 1 | 0.0204 |
| 1 | l-Triiodothyronine [EPC] | 1 | 0.0196 |
| 2 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 22 | 0.0144 |
| 3 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 19 | 0.0084 |
| 4 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 6 | 0.0080 |
| 5 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 9 | 0.0073 |
| 6 | Amino Acid Hypertonic Solution [EPC] | 1 | 0.0063 |
| 7 | Enzyme Stabilizer [EPC] | 7 | 0.0060 |
| 8 | Medium-chain Triglyceride [EPC] | 3 | 0.0054 |
| 9 | GLP-2 Analog [EPC] | 70 | 0.0052 |